Gyroscope Therapeutics Back to portfolio


Company Details

Description

Therapeutics

Fully diluted ownership

72%

Value of Syncona holding

£5.0m

% of nav

0.6%

Description

Gyroscope’s mission is to develop therapeutics against a set of diseases where no meaningful treatment options exist today. Syncona has co-ordinated a diverse set of domains from a number of different UK Universities to found the Company. The synthesis of these domains represents a novel approach to the targeted diseases.
Currently based in London, the Company is recruiting its initial team. A formal company launch will follow later this year.